The 2024 National Disruptive Technology Innovation Competition was launched in Guangzhou on June 16th, spanning over two months. Adopting a "self-organized + league" model akin to the Olympics, the event progressed through domain-specific rounds and a national final to select the ultimate winning projects. MingCeler Bio and the Guangzhou Laboratory's project, "Rapid Generation of Gene-Edited Animal Models Bypassing Traditional Breeding," stood out among thousands of high-quality national entries and ultimately won the Top Award in the finals, earning prestigious recognition as a "disruptive technology."

 

The industrialization of MingCeler's TurboMice™ tetraploid complementation technology can provide rapid, efficient, and high-quality custom services for generating various genetically modified mouse models to global university, research institution, hospital, and pharmaceutical R&D teams in life sciences. With a leading advantage in model generation cycle time worldwide, this technology can significantly support China's vaccine development, new drug R&D, precision medicine, and emergency public health research initiatives. It also enables the rapid preparation of complex animal models needed for disease research, promising to substantially accelerate progress in life science research.

 

The journey of innovation never stops. MingCeler Bio will continue to focus on the R&D of a new generation of animal model generation technology—the TurboMice™ tetraploid complementation technology—to provide superior mouse models and customization services, empowering the rapid development of the biomedicine industry with innovative technology!